受强制性开放获取政策约束的文章 - Kyohei Nakamura M.D., Ph.D.了解详情
无法在其他位置公开访问的文章：2 篇
Targeting an adenosine-mediated “don’t eat me signal” augments anti-lymphoma immunity by anti-CD20 monoclonal antibody
K Nakamura, M Casey, H Oey, F Vari, J Stagg, MK Gandhi, MJ Smyth
Leukemia 34 (10), 2708-2721, 2020
强制性开放获取政策： National Health and Medical Research Council, Australia
Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma
M Casey, K Segawa, SC Law, MB Sabdia, B Nowlan, B Salik, C Lee, ...
Leukemia 37 (2), 379-387, 2023
强制性开放获取政策： National Health and Medical Research Council, Australia
可在其他位置公开访问的文章：26 篇
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Y Gao, F Souza-Fonseca-Guimaraes, T Bald, SS Ng, A Young, SF Ngiow, ...
Nature immunology 18 (9), 1004-1015, 2017
强制性开放获取政策： National Health and Medical Research Council, Australia, German Research …
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment
K Nakamura, MJ Smyth
Cellular & molecular immunology 17 (1), 1-12, 2020
强制性开放获取政策： National Health and Medical Research Council, Australia
TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma
C Guillerey, H Harjunpää, N Carrié, S Kassem, T Teo, K Miles, ...
Blood, The Journal of the American Society of Hematology 132 (16), 1689-1694, 2018
强制性开放获取政策： National Health and Medical Research Council, Australia
Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy
N Glodde, T Bald, D van den Boorn-Konijnenberg, K Nakamura, ...
Immunity 47 (4), 789-802. e9, 2017
强制性开放获取政策： National Health and Medical Research Council, Australia, German Research …
Targeting CD39 in cancer reveals an extracellular ATP-and inflammasome-driven tumor immunity
XY Li, AK Moesta, C Xiao, K Nakamura, M Casey, H Zhang, J Madore, ...
Cancer discovery 9 (12), 1754-1773, 2019
强制性开放获取政策： US Department of Defense, US National Institutes of Health, National Health …
Dysregulated IL-18 is a key driver of immunosuppression and a possible therapeutic target in the multiple myeloma microenvironment
K Nakamura, S Kassem, A Cleynen, ML Chretien, C Guillerey, EM Putz, ...
Cancer cell 33 (4), 634-648. e5, 2018
强制性开放获取政策： US National Institutes of Health, Austrian Science Fund, National Health and …
Targeting cancer‐related inflammation in the era of immunotherapy
K Nakamura, MJ Smyth
Immunology and cell biology 95 (4), 325-332, 2017
强制性开放获取政策： National Health and Medical Research Council, Australia
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation
SS Ng, F De Labastida Rivera, J Yan, D Corvino, I Das, P Zhang, R Kuns, ...
Nature immunology 21 (10), 1205-1218, 2020
强制性开放获取政策： US National Institutes of Health, National Health and Medical Research …
Cancer immunoediting and immune dysregulation in multiple myeloma
K Nakamura, MJ Smyth, L Martinet
Blood, The Journal of the American Society of Hematology 136 (24), 2731-2740, 2020
强制性开放获取政策： National Health and Medical Research Council, Australia
Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies
C Guillerey, K Nakamura, S Vuckovic, GR Hill, MJ Smyth
Cellular and Molecular Life Sciences 73, 1569-1589, 2016
强制性开放获取政策： National Health and Medical Research Council, Australia
CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8+ T cells
M Braun, AR Aguilera, A Sundarrajan, D Corvino, K Stannard, S Krumeich, ...
Immunity 53 (4), 805-823. e15, 2020
强制性开放获取政策： Swiss National Science Foundation, National Health and Medical Research …
Targeting immune checkpoints in hematological malignancies
B Salik, MJ Smyth, K Nakamura
Journal of hematology & oncology 13 (1), 111, 2020
强制性开放获取政策： National Health and Medical Research Council, Australia
Anticancer activity of a Gold (I) phosphine thioredoxin reductase inhibitor in multiple myeloma
JH Sze, PV Raninga, K Nakamura, M Casey, KK Khanna, ...
Redox Biology 28, 101310, 2020
强制性开放获取政策： National Health and Medical Research Council, Australia
TREM2 marks tumor-associated macrophages
K Nakamura, MJ Smyth
Signal Transduction and Targeted Therapy 5 (1), 233, 2020
强制性开放获取政策： National Health and Medical Research Council, Australia
Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model
C Guillerey, K Nakamura, AC Pichler, D Barkauskas, S Krumeich, ...
JCI insight 4 (14), 2019
强制性开放获取政策： US National Institutes of Health, National Health and Medical Research …
A simple organic solvent precipitation method to improve detection of low molecular weight proteins
P Periasamy, S Rajandran, R Ziegman, M Casey, K Nakamura, H Kore, ...
Proteomics 21 (19), 2100152, 2021
强制性开放获取政策： National Health and Medical Research Council, Australia
The cancer-immunity cycle in multiple myeloma
M Casey, K Nakamura
ImmunoTargets and Therapy, 247-260, 2021
强制性开放获取政策： National Health and Medical Research Council, Australia
Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy
C Jacoberger-Foissac, SJ Blake, J Liu, E McDonald, H Triscott, ...
Journal for ImmunoTherapy of Cancer 8 (2), 2020
强制性开放获取政策： National Health and Medical Research Council, Australia
出版信息和资助信息由计算机程序自动确定